已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial.

医学 微量白蛋白尿 蛋白尿 氯沙坦 2型糖尿病 内科学 糖尿病 随机对照试验 蛋白尿 安慰剂 肾脏疾病 2型糖尿病 糖尿病肾病 泌尿科 疾病 内分泌学 血管紧张素II 血压 肾 替代医学 病理
作者
Adnan Agha,Wasim Amer,Eram Anwar,Kaukab Bashir
出处
期刊:PubMed [National Institutes of Health]
卷期号:20 (3): 429-35 被引量:20
链接
标识
摘要

Type 2 diabetes mellitus (T2DM) is a worldwide pandemic that may lead to diabetic kidney disease (DKD), a complication which is the single most important and globally prevalent cause of chronic kidney disease. Microalbuminuria has been shown to be an early indicator of DKD and data suggest that angiotensin receptor blockers (ARBs) reduce urinary albumin excretion and retard the progression of renal disease in hypertensive T2DM patients. However, the effects of ARBs on preventing microalbuminuria and ensuing DKD in normotensive patients with T2DM is yet to be fully established. The objective of this study is to assess the anti-microalbuminuric effects of losar-tan therapy versus placebo in normotensive T2DM patients. This randomized single blinded controlled trial was performed at the Diabetic Clinic, Jinnah Hospital, Lahore over a period of 10 months. A total of 361 normotensive patients with T2DM and microalbuminuria were selected; of them, 171 patients were randomly allocated to the test group and 190 enrolled into the control group. The patients in the test group were started on losartan 50 mg/day for a six month period while those in the control group were put on vitamin B-12 500 mcg/day. The patients as well as the primary attending phy-sicians/lab evaluators were blinded to the study. All study patients were followed up on a monthly basis. Quantitative microalbuminuria was tested at the beginning and at the end of the study. Out of the 171 patients in the test group, 149 (87.1%) had significant reduction of albuminuria by > 30% of their baseline (mean 101.9 +/- 21.7 baseline and, 47.5 +/- 12.9 post-therapy). The corresponding values for albuminuria in the 190 patients in the control group was mean 104.7 +/- 26.3 baseline and post 6-month mean 103.9 +/- 22.9, with P< 0.0001. The anti-albuminuric effect of losartan was reversible as seen on re-checking the urinary albumin two months after discontinuation of treatment. Our study shows that losartan was well tolerated and demonstrated significant anti-proteinuric effects in patients with T2DM with early nephropathy independent of hypertension.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
彭于晏的应助被00hello00采纳,获得10
1秒前
自私的猫完成签到,获得积分10
3秒前
晚风完成签到 ,获得积分10
4秒前
4秒前
5秒前
qingshenggao完成签到,获得积分10
5秒前
企鹅完成签到 ,获得积分10
6秒前
科研通AI6.4的应助被wentian采纳,获得10
8秒前
9秒前
科研通AI6.2的应助被俏皮以旋采纳,获得10
9秒前
十一一完成签到 ,获得积分10
10秒前
共享精神的应助被俭朴灵竹采纳,获得10
13秒前
倾解完成签到,获得积分10
13秒前
星星完成签到 ,获得积分10
17秒前
18秒前
寒冷水香完成签到,获得积分10
18秒前
20秒前
21秒前
22秒前
斯文败类的应助被zxinran0408采纳,获得10
24秒前
大模型的应助被Okpooko采纳,获得10
24秒前
专一的白发布了新的文献求助10
24秒前
Tenax完成签到,获得积分10
25秒前
强健的秋发布了新的文献求助10
25秒前
Owen的应助被Tohka采纳,获得10
26秒前
无花果的应助被奋斗易真采纳,获得10
26秒前
Ava的应助被zuuyo采纳,获得10
26秒前
漂亮的大碗完成签到,获得积分20
28秒前
优秀绝悟完成签到,获得积分10
28秒前
29秒前
30秒前
31秒前
33秒前
李灿完成签到 ,获得积分10
34秒前
浩懿一发布了新的文献求助10
34秒前
34秒前
ihxy完成签到,获得积分10
35秒前
lee发布了新的文献求助10
36秒前
车仔面关注了科研通微信公众号
36秒前
36秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184646
求助须知:如何正确求助?哪些是违规求助? 9573637
关于积分的说明 21832477
捐赠科研通 7781914
什么是DOI,文献DOI怎么找? 3434404
关于科研通互助平台的介绍 2558498
邀请新用户注册赠送积分活动 2481003